论文部分内容阅读
目的 探讨胃癌病人血清肿瘤坏死因子α(TNFα) 、白细胞介素6(IL6) 和白细胞介素8(IL8) 水平的变化及其临床意义。方法 采用ELISA 法测定35 例胃癌病人血清TNFα、IL6 和IL8 水平,并与胃良性肿瘤组和正常对照组进行比较分析。结果 胃癌病人血清TNFα、IL6 和IL8 水平明显增高( P< 0 .01) ,并与临床分期有关(P < 0 .05) ,病灶切除后血清TNFα、IL6和IL8 水平明显降低(P< 0 .05) 。结论 胃癌病人有细胞免疫功能紊乱,血清中TNFα、IL6 和IL8 水平的增高可能与疾病的发生、发展有关,血清TNFα、IL6 和IL8 可作为胃癌病人病情判断和疗效的观察指标之一。
Objective To investigate the changes and clinical significance of serum tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8) levels in patients with gastric cancer. Methods The levels of serum TNFα, IL6 and IL8 in 35 patients with gastric cancer were measured by ELISA. The results were compared with those of benign tumors and normal controls. Results The levels of serum TNFα, IL6 and IL8 in patients with gastric cancer were significantly higher (P 0. 01) and correlated with clinical stages (P 0.05). Serum TNFα and IL6 after resection of the lesions. The level of IL-8 was significantly lower (P < 0.05). Conclusions The patients with gastric cancer have disordered cellular immune function. The increase of serum TNFα, IL6 and IL8 levels may be related to the occurrence and development of the disease. Serum TNFα, IL6 and IL8 may be used as gastric cancer patients. One of the observed indicators of disease condition and efficacy.